Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026)
Ocular Therapeutix (OCUL) reported Raw Materials of $256,000 for Q2 2026, up 16.9% from $219,000 a year earlier but down 10.8% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026) Analysis & Trends
At the end of FY2025, Ocular Therapeutix posted Raw Materials of $202,000, down 5.6% from FY2024.
- Raw Materials has declined for four consecutive years, with a five-year compound annual growth rate of -12.1% (FY2020 to FY2025).
- By year, Raw Materials came in at $214,000 in FY2024 (-29.1%), $302,000 in FY2023 (-2.3%), $309,000 in FY2022 (-20.4%) and $388,000 in FY2021 (+1.0%).
- Five-year quarterly Raw Materials spans a low of $187,000 in Q1 2025 and a high of $388,000 in Q4 2021.
- Year over year, Raw Materials gained in three of the last eight quarters, with an average decline of 5.2%.
- The high point for year-over-year Raw Materials in five years was Q1 2026 (growth of 53.5%); the low point was Q1 2025 (a decline of 43.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $287,000 (Q1 2026), $202,000 (Q4 2025) and $229,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256,000.00 |
| Mar 31, 2026 | 287,000.00 |
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 219,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 196,000.00 |
| Jun 30, 2024 | 267,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 302,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | 309,000.00 |
| Sep 30, 2022 | 317,000.00 |
| Jun 30, 2022 | 325,000.00 |
| Mar 31, 2022 | 332,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Sep 30, 2021 | 370,000.00 |
API Access
Ocular Therapeutix Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();